Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Min Jeong Wang"'
Autor:
Yun Jeong Hong, SeongHee Ho, Jee Hyang Jeong, Kee Hyung Park, SangYun Kim, Min Jeong Wang, Seong Hye Choi, Dong Won Yang, CoSCo study group
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-10 (2023)
Abstract Background Subjective cognitive decline (SCD) is a risk factor for Alzheimer’s disease (AD); however, the rates of cognitive decline are variable according to underlying pathologies and biomarker status. We conducted an observational study
Externí odkaz:
https://doaj.org/article/1d6b0ea2507949e2b698c3e9fe74e8f9
Autor:
Min Jeong Wang, SangHak Yi, Jee-young Han, So Young Park, Jae-Won Jang, In Kook Chun, Sang Eun Kim, Byoung Sub Lee, Gwang Je Kim, Ji Sun Yu, Kuntaek Lim, Sung Min Kang, Young Ho Park, Young Chul Youn, Seong Soo A. An, SangYun Kim
Publikováno v:
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-10 (2017)
Abstract Background Soluble amyloid-β (Aβ) oligomers are the major toxic substances associated with the pathology of Alzheimer’s disease (AD). The ability to measure Aβ oligomer levels in the blood would provide simple and minimally invasive too
Externí odkaz:
https://doaj.org/article/130cb278e26447beb9c7a13f8153d1bf
Autor:
Seong Soo A. An, Byoung-sub Lee, Ji Sun Yu, Kuntaek Lim, Gwang Je Kim, Ryan Lee, Shinwon Kim, Sungmin Kang, Young Ho Park, Min Jeong Wang, Young Soon Yang, Young Chul Youn, SangYun Kim
Publikováno v:
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-10 (2017)
Abstract Background A reliable blood-based assay is required to properly diagnose and monitor Alzheimer’s disease (AD). Many attempts have been made to develop such a diagnostic tool by measuring amyloid-β oligomers (AβOs) in the blood, but none
Externí odkaz:
https://doaj.org/article/178dbb916e81429fbf22238d1d739027
Autor:
Jae-Won Jang, Young Ho Park, So Young Park, Min Jeong Wang, Jae-Sung Lim, Sung-Hun Kim, In KooK Chun, Youngsoon Yang, SangYun Kim
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145658 (2015)
The pathophysiology of transient global amnesia (TGA) is not fully understood. Previous studies using single photon emission computed tomography (SPECT) have reported inconclusive results regarding cerebral perfusion. This study was conducted to iden
Externí odkaz:
https://doaj.org/article/c49ccc9a28944bb3bf9a0c854e12aab8
Autor:
So Young Park, Seong Hee Ho, Yun Jeong Hong, Jee Hyang Jeong, Kee Hyung Park, SangYun Kim, Min Jeong Wang, Seong Hye Choi, Regina E.Y. Kim, Dong Won Yang, Shi Nae Park
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 51:348-356
Introduction: Subjective cognitive decline (SCD) is a self-reported cognitive decline without objective cognitive impairment. The relationship between audiometric hearing loss (HL) and cognitive function has not been reported in SCD. The purpose of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55ac53d7b0e84a82702d82d3cb746ca1
https://doi.org/10.1159/000526230
https://doi.org/10.1159/000526230
Autor:
Seon Young Ryu, Yun Jeong Hong, SeongHee Ho, Jee Hyang Jeong, Kee Hyung Park, SangYun Kim, Min Jeong Wang, Seong Hye Choi, Dong Won Yang
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 51:159-167
Introduction: Subjective cognitive decline (SCD) can be considered as the preclinical manifestation of Alzheimer’s disease (AD). The National Institute on Aging and the Alzheimer’s Association criteria for preclinical AD proposed that subtle cogn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d9a51fe4a14ed9031dfafe447103bd
https://doi.org/10.1159/000523971
https://doi.org/10.1159/000523971
Autor:
SeongHee Ho, Yun Jeong Hong, Jee Hyang Jeong, Kee Hyung Park, SangYun Kim, Min Jeong Wang, Seong Hye Choi, SeungHyun Han, Dong Won Yang
Publikováno v:
Dementia and neurocognitive disorders. 21(4)
Subjective cognitive decline (SCD) refers to the self-perception of cognitive decline with normal performance on objective neuropsychological tests. SCD, which is the first help-seeking stage and the last stage before the clinical disease stage, can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::425c3b2f06c76b17a147e59a5d39b897
https://pubmed.ncbi.nlm.nih.gov/36407288
https://pubmed.ncbi.nlm.nih.gov/36407288
Autor:
YongSoo Shim, Dong Won Yang, SeongHee Ho, Yun Jeong Hong, Jee Hyang Jeong, Kee Hyung Park, SangYun Kim, Min Jeong Wang, Seong Hye Choi, Seung Wan Kang
Publikováno v:
Dementia and neurocognitive disorders. 21(4)
Early detection of subjective cognitive decline (SCD) due to Alzheimer's disease (AD) is important for clinical research and effective prevention and management. This study examined if quantitative electroencephalography (qEEG) could be used for earl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc61b5c8eb6c5bfecf2382dc025be93f
https://pubmed.ncbi.nlm.nih.gov/36407290
https://pubmed.ncbi.nlm.nih.gov/36407290
Autor:
Young Chul Youn, Min Ju Kang, Nayoung Ryoo, Min Jae Baek, Min Jeong Wang, Dong Won Yang, Jung Min Pyun, SangYun Kim, Seong Yoon Kim, Young Ho Park, Jeewon Suh
Publikováno v:
Journal of Korean Medical Science
Multiple neurological complications have been associated with the coronavirus disease-19 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2. This is a narrative review to gather information on all aspects of COVID-19 in el
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5570375d2687ffcd44b13b345faff703
https://doi.org/10.3346/jkms.2020.35.e383
https://doi.org/10.3346/jkms.2020.35.e383
Autor:
Seong Soo A. An, Young Ho Park, Sungmin Kang, So Young Park, Sang Eun Kim, Min Jeong Wang, Gwang Je Kim, In Kook Chun, Kuntaek Lim, Young Chul Youn, SangHak Yi, Jee Young Han, Byoung Sub Lee, SangYun Kim, Ji Sun Yu, Jae-Won Jang
Publikováno v:
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-10 (2017)
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy
Background Soluble amyloid-β (Aβ) oligomers are the major toxic substances associated with the pathology of Alzheimer’s disease (AD). The ability to measure Aβ oligomer levels in the blood would provide simple and minimally invasive tools for AD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8cab56d8329f075b1af7de506b70e41
http://link.springer.com/article/10.1186/s13195-017-0324-0
http://link.springer.com/article/10.1186/s13195-017-0324-0